Correction reveals inaccuracies in biomarker labeling related to Alzheimer's disease pathology.
Correction: Plasma Aβ42/p-Tau217 ratio and p-Tau217 independently predict CSF-defined Alzheimer's disease pathology in a Brazilian admixed cohort Correction on: Rizzi L et al. Front. Aging Neurosci. 18:1773606. doi: 10.3389/fnagi.2026.1773606 There was a mistake in Table 1 as published. The labels referring to plasma p-Tau181 and plasma t-Tau were inadvertently interchanged. Likewise, the labels for plasma Aβ42/p-Tau181 and plasma Aβ42/t-Tau were inadvertently interchanged. The original version of this article has been updated.There was a mistake in Figure 1 as published. The labels referring to plasma p-Tau181 and plasma t-Tau were inadvertently interchanged.The corrected Figure 1 appears below.The original version of this article has been updated.There was an error in the section 3.2 Correlations between plasma and CSF biomarkers, where plasma p-Tau181 and plasma t-Tau were inadvertently interchanged. A correction has been made to the section:"Plasma Aβ42/Aβ40 and plasma Aβ42/t-Tau were moderately correlated with CSF Aβ42 (r = 0.44 and r = 0.43, respectively). Additionally, plasma p-Tau181 showed moderate correlations with CSF p-Tau231/Aβ42 (r = 0.43) and CSF p-Tau231 (r = 0.41)."End of template. If you would like to request a correction for a reason not seen here, please contact the journal's editorial office.
No takes yet. Share an insight, caveat, or question.
Rizzi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: